UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Implementing wealth accumulation financial strategies can significantly enhance your financial situation. Explore these strategies now.
19,917 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Retirement savings aren’t built in a single year—they grow through key age milestones. This guide shows what to aim f...
IREN is positioning itself as a key AI infrastructure partner as demand for GPU compute grows. This article explores ...
The standard Medicare Part B premium surpassed $200 per month in 2026, up $17.90 from 2025. With COLA growth lagging ...
When oil surges, mining companies feel the sting long before metals move. This article breaks down how energy costs p...
Apollo Global Management posted strong 2025 revenue and raised its dividend, but the stock has fallen as private cred...
A prominent crypto trader files a lawsuit against Coinbase claiming it refused to return DAI funds stolen in a phishi...
A prominent Trump-backed bitcoin mining venture reported a heavy Q1 loss, triggering a notable slide in its shares. T...
FuelCell Energy jumps 18% in midday trading, powering a broad rally for fuel-cell names as AI infrastructure and grid...
When a hedge fund takes position in a logistics stock, it often signals confidence in the sector's growth prospects a...
Solana just posted a landmark quarter with over $1 trillion in on-chain activity. This article unpacks what that mile...
Rising gas costs push Gen Z to curb discretionary spending, nudging cosmetics brands to cut prices and rethink produc...